Asthma is a long-term lung disease that narrows the air passage with the inflammation, thereby obstructing the breath. Asthma causes breathing difficulty, wheezing, chest tightness and also cough for the age groups especially in childhood.
Asthma has no cure, but certain medications can relieve from the severe attacks. In the present days, Nanotechnology is a fast growing research priority. Application of nanotechnology has significantly increased in different medical spheres diagnostics, treatment and drug delivery systems for future generations. Journal of Nanobiotechnology, a medical Journal describes several reports on asthma and allergies.
There are novel and sophisticated advancements into the diagnostic approach and treatment options of asthma. Center for Nanomaterials and Sensor Development at Stony Brook has developed a personalized asthma monitor using nanotechnology to detect known airway inflammation biomarkers in the breath. Harvard University team also developed a human airway muscle-on-a-chip that could be used to test emerging drugs because it accurately mimics the passage smooth muscle contracts in the human airway, under normal circumstances and also during asthma attack.
According to the data published in the Journal Lab on a Chip, the technique also offers a window into the cellular responses within the tissue during an asthmatic attack. Further research is warranted to elucidate the long term benefits of nanotechnology into the asthma treatment.